-
1
-
-
0032580348
-
Human gene therapy
-
10.1038/32801
-
Anderson WF (1998) Human gene therapy. Nature 392:25-30 10.1038/32801
-
(1998)
Nature
, vol.392
, pp. 25-30
-
-
Anderson, W.F.1
-
2
-
-
0027595949
-
The basic science of gene therapy
-
1:CAS:528:DyaK3sXktVSisbg%3D
-
Mulligan RC (1993) The basic science of gene therapy. Science 260:926-932 1:CAS:528:DyaK3sXktVSisbg%3D
-
(1993)
Science
, vol.260
, pp. 926-932
-
-
Mulligan, R.C.1
-
3
-
-
0028875936
-
Transfer of genes to humans: Early lessons and obstacles to success
-
1:CAS:528:DyaK2MXovVeku7s%3D
-
Crystal RG (1995) Transfer of genes to humans: Early lessons and obstacles to success. Science 270:404-410 1:CAS:528:DyaK2MXovVeku7s%3D
-
(1995)
Science
, vol.270
, pp. 404-410
-
-
Crystal, R.G.1
-
4
-
-
0038311930
-
Current status of gene therapy for inherited lung diseases
-
10.1146/annurev.physiol.65.092101.142426
-
Driskell RA, Engelhardt JF (2003) Current status of gene therapy for inherited lung diseases. Annu Rev Physiol 65:585-612 10.1146/annurev.physiol.65.092101.142426
-
(2003)
Annu. Rev. Physiol.
, vol.65
, pp. 585-612
-
-
Driskell, R.A.1
Engelhardt, J.F.2
-
5
-
-
0038745599
-
Progress and problems with the use of viral vectors for gene therapy
-
10.1038/nrg1066
-
Thomas CE, Ehrhardt A, Kay MA (2003) Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4:346-358 10.1038/nrg1066
-
(2003)
Nat. Rev. Genet.
, vol.4
, pp. 346-358
-
-
Thomas, C.E.1
Ehrhardt, A.2
Kay, M.A.3
-
6
-
-
0037448352
-
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
-
10.1056/NEJM200301163480314
-
Hacein-Bey-Abina S, Kalle C von, Schmidt M, Le Deist F, Wulffraat N, McIntyre E, Radford I, Villeval JL, Fraser CC, Cavazzana-Calvo M, Fischer A (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348:255-256 10.1056/NEJM200301163480314
-
(2003)
N. Engl. J. Med.
, vol.348
, pp. 255-256
-
-
Hacein-Bey-Abina, S.1
von Kalle, C.2
Schmidt, M.3
Le Deist, F.4
Wulffraat, N.5
McIntyre, E.6
Radford, I.7
Villeval, J.L.8
Fraser, C.C.9
Cavazzana-Calvo, M.10
Fischer, A.11
-
7
-
-
0142089747
-
Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer
-
10.1016/j.ymgme.2003.08.016
-
Raper SE, Chirmule N, Lee FS, Wivel NA, Bagg A, Gao GP, Wilson JM, Batshaw ML (2003) Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 80:148-158 10.1016/j.ymgme.2003.08.016
-
(2003)
Mol. Genet. Metab.
, vol.80
, pp. 148-158
-
-
Raper, S.E.1
Chirmule, N.2
Lee, F.S.3
Wivel, N.A.4
Bagg, A.5
Gao, G.P.6
Wilson, J.M.7
Batshaw, M.L.8
-
8
-
-
0033844756
-
Antivector and antitransgene host responses in gene therapy
-
1:CAS:528:DC%2BD3cXmtl2qtrs%3D
-
Hackett NR, Kaminsky SM, Sondhi D, Crystal RG (2000) Antivector and antitransgene host responses in gene therapy. Curr Opin Mol Ther 2:376-382 1:CAS:528:DC%2BD3cXmtl2qtrs%3D
-
(2000)
Curr. Opin. Mol. Ther.
, vol.2
, pp. 376-382
-
-
Hackett, N.R.1
Kaminsky, S.M.2
Sondhi, D.3
Crystal, R.G.4
-
9
-
-
0142084745
-
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1
-
10.1126/science.1088547
-
Hacein-Bey-Abina S, Kalle C von, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, de Saint BG, Alexander I, Wintergerst U, Frebourg T, Aurias A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, Macintyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana-Calvo M (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415-419 10.1126/science.1088547
-
(2003)
Science
, vol.302
, pp. 415-419
-
-
Hacein-Bey-Abina, S.1
von Kalle, C.2
Schmidt, M.3
McCormack, M.P.4
Wulffraat, N.5
Leboulch, P.6
Lim, A.7
Osborne, C.S.8
Pawliuk, R.9
Morillon, E.10
Sorensen, R.11
Forster, A.12
Fraser, P.13
Cohen, J.I.14
de Saint, B.G.15
Alexander, I.16
Wintergerst, U.17
Frebourg, T.18
Aurias, A.19
Stoppa-Lyonnet, D.20
Romana, S.21
Radford-Weiss, I.22
Gross, F.23
Valensi, F.24
Delabesse, E.25
Macintyre, E.26
Sigaux, F.27
Soulier, J.28
Leiva, L.E.29
Wissler, M.30
Prinz, C.31
Rabbitts, T.H.32
Le Deist, F.33
Fischer, A.34
Cavazzana-Calvo, M.35
more..
-
10
-
-
1342289322
-
Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency
-
10.1056/NEJMra032207
-
McCormack MP, Rabbitts TH (2004) Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 350:913-922 10.1056/NEJMra032207
-
(2004)
N. Engl. J. Med.
, vol.350
, pp. 913-922
-
-
McCormack, M.P.1
Rabbitts, T.H.2
-
11
-
-
2342453844
-
Gene therapy in renal diseases
-
10.1111/j.1523-1755.2004.05409.x
-
Imai E, Takabatake Y, Mizui M, Isaka Y (2004) Gene therapy in renal diseases. Kidney Int 65:1551-1555 10.1111/j.1523-1755.2004.05409.x
-
(2004)
Kidney Int.
, vol.65
, pp. 1551-1555
-
-
Imai, E.1
Takabatake, Y.2
Mizui, M.3
Isaka, Y.4
-
12
-
-
0038102806
-
Applications of gene therapy to kidney disease
-
10.1097/00041552-200307000-00013
-
Hanss B, Bruggeman LA (2003) Applications of gene therapy to kidney disease. Curr Opin Nephrol Hypertens 12:439-445 10.1097/00041552-200307000-00013
-
(2003)
Curr. Opin. Nephrol. Hypertens.
, vol.12
, pp. 439-445
-
-
Hanss, B.1
Bruggeman, L.A.2
-
13
-
-
0038115345
-
Renal gene transfer: Nonviral approaches
-
10.1385/MB:24:3:283
-
Lien YH, Lai LW (2003) Renal gene transfer: Nonviral approaches. Mol Biotechnol 24:283-294 10.1385/MB:24:3:283
-
(2003)
Mol. Biotechnol.
, vol.24
, pp. 283-294
-
-
Lien, Y.H.1
Lai, L.W.2
-
14
-
-
0029837352
-
Molecular therapy for renal diseases
-
1:CAS:528:DyaK28XmtlKgsb0%3D
-
Lipkowitz MS, Klotman ME, Bruggeman LA, Nicklin P, Hanss B, Rappaport J, Klotman PE (1996) Molecular therapy for renal diseases. Am J Kidney Dis 28:475-492 1:CAS:528:DyaK28XmtlKgsb0%3D
-
(1996)
Am. J. Kidney Dis.
, vol.28
, pp. 475-492
-
-
Lipkowitz, M.S.1
Klotman, M.E.2
Bruggeman, L.A.3
Nicklin, P.4
Hanss, B.5
Rappaport, J.6
Klotman, P.E.7
-
15
-
-
0027361622
-
Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice
-
10.1038/ng1093-135
-
Alton EW, Middleton PG, Caplen NJ, Smith SN, Steel DM, Munkonge FM, Jeffery PK, Geddes DM, Hart SL, Williamson R (1993) Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat Genet 5:135-142 10.1038/ng1093-135
-
(1993)
Nat. Genet.
, vol.5
, pp. 135-142
-
-
Alton, E.W.1
Middleton, P.G.2
Caplen, N.J.3
Smith, S.N.4
Steel, D.M.5
Munkonge, F.M.6
Jeffery, P.K.7
Geddes, D.M.8
Hart, S.L.9
Williamson, R.10
-
16
-
-
19244363903
-
Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung
-
1:CAS:528:DyaK28XmtF2ksLY%3D
-
Lee ER, Marshall J, Siegel CS, Jiang C, Yew NS, Nichols MR, Nietupski JB, Ziegler RJ, Lane MB, Wang KX, Wan NC, Scheule RK, Harris DJ, Smith AE, Cheng SH (1996) Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum Gene Ther 7:1701-1717 1:CAS:528:DyaK28XmtF2ksLY%3D
-
(1996)
Hum. Gene Ther.
, vol.7
, pp. 1701-1717
-
-
Lee, E.R.1
Marshall, J.2
Siegel, C.S.3
Jiang, C.4
Yew, N.S.5
Nichols, M.R.6
Nietupski, J.B.7
Ziegler, R.J.8
Lane, M.B.9
Wang, K.X.10
Wan, N.C.11
Scheule, R.K.12
Harris, D.J.13
Smith, A.E.14
Cheng, S.H.15
-
18
-
-
0036968169
-
Gene delivery using herpes simplex virus vectors
-
10.1089/104454902762053864
-
Burton EA, Fink DJ, Glorioso JC (2002) Gene delivery using herpes simplex virus vectors. DNA Cell Biol 21:915-936 10.1089/104454902762053864
-
(2002)
DNA Cell Biol.
, vol.21
, pp. 915-936
-
-
Burton, E.A.1
Fink, D.J.2
Glorioso, J.C.3
-
19
-
-
0000557447
-
Adenoviridae: The viruses and their replication
-
Fields BN, Knipe DM, Howley PM (eds) Lippincott-Raven, Philadelphia
-
Shenk T (1996) Adenoviridae: The viruses and their replication. In: Fields BN, Knipe DM, Howley PM (eds) Fields virology. Lippincott-Raven, Philadelphia, pp 2111-2148
-
(1996)
Fields Virology
, pp. 2111-2148
-
-
Shenk, T.1
-
21
-
-
0028168641
-
Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis
-
10.1038/ng0994-42
-
Crystal RG, McElvaney NG, Rosenfeld MA, Chu CS, Mastrangeli A, Hay JG, Brody SL, Jaffe HA, Eissa NT, Danel C (1994) Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet 8:42-51 10.1038/ng0994-42
-
(1994)
Nat. Genet.
, vol.8
, pp. 42-51
-
-
Crystal, R.G.1
McElvaney, N.G.2
Rosenfeld, M.A.3
Chu, C.S.4
Mastrangeli, A.5
Hay, J.G.6
Brody, S.L.7
Jaffe, H.A.8
Eissa, N.T.9
Danel, C.10
-
22
-
-
0030756821
-
Gene therapy with recombinant adenovirus vectors: Evaluation of the host immune response
-
10.1016/S0165-2478(97)00049-7
-
Christ M, Lusky M, Stoeckel F, Dreyer D, Dieterle A, Michou AI, Pavirani A, Mehtali M (1997) Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response. Immunol Lett 57:19-25 10.1016/S0165-2478(97)00049-7
-
(1997)
Immunol. Lett.
, vol.57
, pp. 19-25
-
-
Christ, M.1
Lusky, M.2
Stoeckel, F.3
Dreyer, D.4
Dieterle, A.5
Michou, A.I.6
Pavirani, A.7
Mehtali, M.8
-
23
-
-
0036145350
-
A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency
-
10.1089/10430340152712719
-
Raper SE, Yudkoff M, Chirmule N, Gao GP, Nunes F, Haskal ZJ, Furth EE, Propert KJ, Robinson MB, Magosin S, Simoes H, Speicher L, Hughes J, Tazelaar J, Wivel NA, Wilson JM, Batshaw ML (2002) A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency. Hum Gene Ther 13:163-175 10.1089/10430340152712719
-
(2002)
Hum. Gene Ther.
, vol.13
, pp. 163-175
-
-
Raper, S.E.1
Yudkoff, M.2
Chirmule, N.3
Gao, G.P.4
Nunes, F.5
Haskal, Z.J.6
Furth, E.E.7
Propert, K.J.8
Robinson, M.B.9
Magosin, S.10
Simoes, H.11
Speicher, L.12
Hughes, J.13
Tazelaar, J.14
Wivel, N.A.15
Wilson, J.M.16
Batshaw, M.L.17
-
24
-
-
0642366702
-
Gene therapy for human malignant brain tumors
-
1:CAS:528:DC%2BD3sXnsFyjtrg%3D
-
Rainov NG, Ren H (2003) Gene therapy for human malignant brain tumors. Cancer J 9:180-188 1:CAS:528:DC%2BD3sXnsFyjtrg%3D
-
(2003)
Cancer J.
, vol.9
, pp. 180-188
-
-
Rainov, N.G.1
Ren, H.2
-
25
-
-
0141958608
-
Gene therapy using an adenovirus vector for apoptosis-related genes is a highly effective therapeutic modality for killing glioma cells
-
1:CAS:528:DC%2BD3sXitFyrsrc%3D
-
Shinoura N, Hamada H (2003) Gene therapy using an adenovirus vector for apoptosis-related genes is a highly effective therapeutic modality for killing glioma cells. Curr Gene Ther 3:147-153 1:CAS:528:DC%2BD3sXitFyrsrc%3D
-
(2003)
Curr. Gene Ther.
, vol.3
, pp. 147-153
-
-
Shinoura, N.1
Hamada, H.2
-
26
-
-
0042827491
-
Comparison of replication-selective, oncolytic viruses for the treatment of human cancers
-
14513677
-
Wildner O (2003) Comparison of replication-selective, oncolytic viruses for the treatment of human cancers. Curr Opin Mol Ther 5:351-361 14513677
-
(2003)
Curr. Opin. Mol. Ther.
, vol.5
, pp. 351-361
-
-
Wildner, O.1
-
27
-
-
0033520056
-
Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
-
1:CAS:528:DyaK1MXltlOmsLg%3D
-
Rosengart TK, Lee LY, Patel SR, Sanborn TA, Parikh M, Bergman GW, Hachamovitch R, Szulc M, Kligfield PD, Okin PM, Hahn RT, Devereux RB, Post MR, Hackett NR, Foster T, Grasso TM, Lesser ML, Isom OW, Crystal RG (1999) Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100:468-474 1:CAS:528:DyaK1MXltlOmsLg%3D
-
(1999)
Circulation
, vol.100
, pp. 468-474
-
-
Rosengart, T.K.1
Lee, L.Y.2
Patel, S.R.3
Sanborn, T.A.4
Parikh, M.5
Bergman, G.W.6
Hachamovitch, R.7
Szulc, M.8
Kligfield, P.D.9
Okin, P.M.10
Hahn, R.T.11
Devereux, R.B.12
Post, M.R.13
Hackett, N.R.14
Foster, T.15
Grasso, T.M.16
Lesser, M.L.17
Isom, O.W.18
Crystal, R.G.19
-
28
-
-
0037297359
-
Gene therapy progress and prospects: Therapeutic angiogenesis for limb and myocardial ischemia
-
10.1038/sj.gt.3301969
-
Khan TA, Sellke FW, Laham RJ (2003) Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia. Gene Ther 10:285-291 10.1038/sj.gt.3301969
-
(2003)
Gene Ther.
, vol.10
, pp. 285-291
-
-
Khan, T.A.1
Sellke, F.W.2
Laham, R.J.3
-
29
-
-
0029951519
-
A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier
-
10.1006/viro.1996.0239
-
Xiang ZQ, Yang Y, Wilson JM, Ertl HC (1996) A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219:220-227 10.1006/viro.1996.0239
-
(1996)
Virology
, vol.219
, pp. 220-227
-
-
Xiang, Z.Q.1
Yang, Y.2
Wilson, J.M.3
Ertl, H.C.4
-
30
-
-
1542299092
-
Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors
-
10.1146/annurev.med.55.091902.104344
-
Shiver JW, Emini EA (2004) Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors. Annu Rev Med 55:355-372 10.1146/annurev.med.55.091902.104344
-
(2004)
Annu. Rev. Med.
, vol.55
, pp. 355-372
-
-
Shiver, J.W.1
Emini, E.A.2
-
31
-
-
0042739176
-
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates
-
10.1038/nature01876
-
Sullivan NJ, Geisbert TW, Geisbert JB, Xu L, Yang ZY, Roederer M, Koup RA, Jahrling PB, Nabel GJ (2003) Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature 424:681-684 10.1038/nature01876
-
(2003)
Nature
, vol.424
, pp. 681-684
-
-
Sullivan, N.J.1
Geisbert, T.W.2
Geisbert, J.B.3
Xu, L.4
Yang, Z.Y.5
Roederer, M.6
Koup, R.A.7
Jahrling, P.B.8
Nabel, G.J.9
-
32
-
-
10744232251
-
Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses
-
10.1128/JVI.78.5.2572-2580.2004
-
Worgall S, Busch A, Rivara M, Bonnyay D, Leopold PL, Merritt R, Hackett NR, Rovelink PW, Bruder JT, Wickham TJ, Kovesdi I, Crystal RG (2004) Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses. J Virol 78:2572-2580 10.1128/JVI.78.5.2572-2580.2004
-
(2004)
J. Virol.
, vol.78
, pp. 2572-2580
-
-
Worgall, S.1
Busch, A.2
Rivara, M.3
Bonnyay, D.4
Leopold, P.L.5
Merritt, R.6
Hackett, N.R.7
Rovelink, P.W.8
Bruder, J.T.9
Wickham, T.J.10
Kovesdi, I.11
Crystal, R.G.12
-
33
-
-
0034782151
-
High-capacity 'gutless' adenoviral vectors
-
1:CAS:528:DC%2BD3MXotlyqtbg%3D
-
Kochanek S, Schiedner G, Volpers C (2001) High-capacity 'gutless' adenoviral vectors. Curr Opin Mol Ther 3:454-463 1:CAS:528:DC%2BD3MXotlyqtbg%3D
-
(2001)
Curr. Opin. Mol. Ther.
, vol.3
, pp. 454-463
-
-
Kochanek, S.1
Schiedner, G.2
Volpers, C.3
-
34
-
-
0031916435
-
Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity
-
10.1038/ng0298-180
-
Schiedner G, Morral N, Parks RJ, Wu Y, Koopmans SC, Langston C, Graham FL, Beaudet AL, Kochanek S (1998) Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet 18:180-183 10.1038/ng0298-180
-
(1998)
Nat. Genet.
, vol.18
, pp. 180-183
-
-
Schiedner, G.1
Morral, N.2
Parks, R.J.3
Wu, Y.4
Koopmans, S.C.5
Langston, C.6
Graham, F.L.7
Beaudet, A.L.8
Kochanek, S.9
-
35
-
-
0033643006
-
Molecular biology of adeno-associated viruses
-
1:CAS:528:DC%2BD3cXntFKltLw%3D
-
Linden RM, Berns KI (2000) Molecular biology of adeno-associated viruses. Contrib Microbiol 4:68-84 1:CAS:528:DC%2BD3cXntFKltLw%3D
-
(2000)
Contrib. Microbiol.
, vol.4
, pp. 68-84
-
-
Linden, R.M.1
Berns, K.I.2
-
36
-
-
1542369977
-
From virus evolution to vector revolution: Use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy
-
1:CAS:528:DC%2BD3sXlsVSjs7g%3D
-
Grimm D, Kay MA (2003) From virus evolution to vector revolution: Use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr Gene Ther 3:281-304 1:CAS:528:DC%2BD3sXlsVSjs7g%3D
-
(2003)
Curr. Gene Ther.
, vol.3
, pp. 281-304
-
-
Grimm, D.1
Kay, M.A.2
-
37
-
-
0037947557
-
Adeno-associated viruses undergo substantial evolution in primates during natural infections
-
10.1073/pnas.0937739100
-
Gao G, Alvira MR, Somanathan S, Lu Y, Vandenberghe LH, Rux JJ, Calcedo R, Sanmiguel J, Abbas Z, Wilson JM (2003) Adeno-associated viruses undergo substantial evolution in primates during natural infections. Proc Natl Acad Sci U S A 100:6081-6086 10.1073/pnas.0937739100
-
(2003)
Proc. Natl. Acad. Sci. U S A
, vol.100
, pp. 6081-6086
-
-
Gao, G.1
Alvira, M.R.2
Somanathan, S.3
Lu, Y.4
Vandenberghe, L.H.5
Rux, J.J.6
Calcedo, R.7
Sanmiguel, J.8
Abbas, Z.9
Wilson, J.M.10
-
38
-
-
0142154212
-
AAV-mediated gene therapy for hemophilia
-
1:CAS:528:DC%2BD3sXptFKitLk%3D
-
Couto LB, Pierce GF (2003) AAV-mediated gene therapy for hemophilia. Curr Opin Mol Ther 5:517-523 1:CAS:528:DC%2BD3sXptFKitLk%3D
-
(2003)
Curr. Opin. Mol. Ther.
, vol.5
, pp. 517-523
-
-
Couto, L.B.1
Pierce, G.F.2
-
39
-
-
0042827473
-
AAV-based gene transfer
-
14513679
-
Buning H, Nicklin SA, Perabo L, Hallek M, Baker AH (2003) AAV-based gene transfer. Curr Opin Mol Ther 5:367-375 14513679
-
(2003)
Curr. Opin. Mol. Ther.
, vol.5
, pp. 367-375
-
-
Buning, H.1
Nicklin, S.A.2
Perabo, L.3
Hallek, M.4
Baker, A.H.5
-
40
-
-
0037143294
-
Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain
-
10.1089/104303402760128612
-
Janson C, McPhee S, Bilaniuk L, Haselgrove J, Testaiuti M, Freese A, Wang DJ, Shera D, Hurh P, Rupin J, Saslow E, Goldfarb O, Goldberg M, Larijani G, Sharrar W, Liouterman L, Camp A, Kolodny E, Samulski J, Leone P (2002) Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain. Hum Gene Ther 13:1391-1412 10.1089/104303402760128612
-
(2002)
Hum. Gene Ther.
, vol.13
, pp. 1391-1412
-
-
Janson, C.1
McPhee, S.2
Bilaniuk, L.3
Haselgrove, J.4
Testaiuti, M.5
Freese, A.6
Wang, D.J.7
Shera, D.8
Hurh, P.9
Rupin, J.10
Saslow, E.11
Goldfarb, O.12
Goldberg, M.13
Larijani, G.14
Sharrar, W.15
Liouterman, L.16
Camp, A.17
Kolodny, E.18
Samulski, J.19
Leone, P.20
more..
-
41
-
-
0028169741
-
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain
-
10.1038/ng1094-148
-
Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL, During MJ (1994) Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 8:148-154 10.1038/ng1094-148
-
(1994)
Nat. Genet.
, vol.8
, pp. 148-154
-
-
Kaplitt, M.G.1
Leone, P.2
Samulski, R.J.3
Xiao, X.4
Pfaff, D.W.5
O'Malley, K.L.6
During, M.J.7
-
42
-
-
1542740191
-
AAV-mediated gene transfer to skeletal muscle
-
1:CAS:528:DC%2BD3sXpsVWksLY%3D
-
Herzog RW (2004) AAV-mediated gene transfer to skeletal muscle. Methods Mol Biol 246:179-194 1:CAS:528:DC%2BD3sXpsVWksLY%3D
-
(2004)
Methods Mol. Biol.
, vol.246
, pp. 179-194
-
-
Herzog, R.W.1
-
43
-
-
0037189401
-
Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning
-
10.1126/science.1070104
-
Aiuti A, Slavin S, Aker M, Ficara F, Deola S, Mortellaro A, Morecki S, Andolfi G, Tabucchi A, Carlucci F, Marinello E, Cattaneo F, Vai S, Servida P, Miniero R, Roncarolo MG, Bordignon C (2002) Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296:2410-2413 10.1126/science.1070104
-
(2002)
Science
, vol.296
, pp. 2410-2413
-
-
Aiuti, A.1
Slavin, S.2
Aker, M.3
Ficara, F.4
Deola, S.5
Mortellaro, A.6
Morecki, S.7
Andolfi, G.8
Tabucchi, A.9
Carlucci, F.10
Marinello, E.11
Cattaneo, F.12
Vai, S.13
Servida, P.14
Miniero, R.15
Roncarolo, M.G.16
Bordignon, C.17
-
44
-
-
0034724857
-
Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
-
10.1126/science.288.5466.669
-
Cavazzana-Calvo M, Hacein-Bey S, Saint BG de, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Deist FL, Fischer A (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288:669-672 10.1126/science.288.5466.669
-
(2000)
Science
, vol.288
, pp. 669-672
-
-
Cavazzana-Calvo, M.1
Hacein-Bey, S.2
de Saint, B.G.3
Gross, F.4
Yvon, E.5
Nusbaum, P.6
Selz, F.7
Hue, C.8
Certain, S.9
Casanova, J.L.10
Bousso, P.11
Deist, F.L.12
Fischer, A.13
-
45
-
-
1542740116
-
Gene delivery by lentivirus vectors. An overview
-
1:CAS:528:DC%2BD3sXpsVWktr8%3D
-
Kafri T (2004) Gene delivery by lentivirus vectors. An overview. Methods Mol Biol 246:367-390 1:CAS:528:DC%2BD3sXpsVWktr8%3D
-
(2004)
Methods Mol. Biol.
, vol.246
, pp. 367-390
-
-
Kafri, T.1
-
46
-
-
0036819745
-
Therapeutic globin gene delivery using lentiviral vectors
-
1:CAS:528:DC%2BD3sXhtlKkt7g%3D
-
Rivella S, Sadelain M (2002) Therapeutic globin gene delivery using lentiviral vectors. Curr Opin Mol Ther 4:505-514 1:CAS:528:DC%2BD3sXhtlKkt7g%3D
-
(2002)
Curr. Opin. Mol. Ther.
, vol.4
, pp. 505-514
-
-
Rivella, S.1
Sadelain, M.2
-
47
-
-
0142227237
-
Targeting survival: Integration site selection by retroviruses and LTR-retrotransposons
-
10.1016/S0092-8674(03)00760-8
-
Bushman FD (2003) Targeting survival: Integration site selection by retroviruses and LTR-retrotransposons. Cell 115:135-138 10.1016/S0092-8674(03)00760-8
-
(2003)
Cell
, vol.115
, pp. 135-138
-
-
Bushman, F.D.1
-
48
-
-
3342878376
-
Prospects and implications of using chromatin insulators in gene therapy and transgenesis
-
10.1002/bies.20059
-
Recillas-Targa F, Valadez-Graham V, Farrell CM (2004) Prospects and implications of using chromatin insulators in gene therapy and transgenesis. Bioessays 26:796-807 10.1002/bies.20059
-
(2004)
Bioessays
, vol.26
, pp. 796-807
-
-
Recillas-Targa, F.1
Valadez-Graham, V.2
Farrell, C.M.3
-
49
-
-
0037841763
-
Transcription start regions in the human genome are favored targets for MLV integration
-
10.1126/science.1083413
-
Wu X, Li Y, Crise B, Burgess SM (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science 300:1749-1751 10.1126/science.1083413
-
(2003)
Science
, vol.300
, pp. 1749-1751
-
-
Wu, X.1
Li, Y.2
Crise, B.3
Burgess, S.M.4
-
50
-
-
0037790709
-
Immune responses to replication-defective HSV-1 type vectors within the CNS: Implications for gene therapy
-
10.1038/sj.gt.3302047
-
Bowers WJ, Olschowka JA, Federoff HJ (2003) Immune responses to replication-defective HSV-1 type vectors within the CNS: Implications for gene therapy. Gene Ther 10:941-945 10.1038/sj.gt.3302047
-
(2003)
Gene Ther.
, vol.10
, pp. 941-945
-
-
Bowers, W.J.1
Olschowka, J.A.2
Federoff, H.J.3
-
51
-
-
0033579358
-
Gene therapy death prompts review of adenovirus vector
-
10.1126/science.286.5448.2244
-
Marshall E (1999) Gene therapy death prompts review of adenovirus vector. Science 286:2244-2245 10.1126/science.286.5448.2244
-
(1999)
Science
, vol.286
, pp. 2244-2245
-
-
Marshall, E.1
-
52
-
-
0036149132
-
Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions
-
10.1089/10430340152712638
-
Harvey BG, Maroni J, O'Donoghue KA, Chu KW, Muscat JC, Pippo AL, Wright CE, Hollmann C, Wisnivesky JP, Kessler PD, Rasmussen HS, Rosengart TK, Crystal RG (2002) Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions. Hum Gene Ther 13:15-63 10.1089/10430340152712638
-
(2002)
Hum. Gene Ther.
, vol.13
, pp. 15-63
-
-
Harvey, B.G.1
Maroni, J.2
O'Donoghue, K.A.3
Chu, K.W.4
Muscat, J.C.5
Pippo, A.L.6
Wright, C.E.7
Hollmann, C.8
Wisnivesky, J.P.9
Kessler, P.D.10
Rasmussen, H.S.11
Rosengart, T.K.12
Crystal, R.G.13
-
53
-
-
10744226638
-
Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunity
-
10.1038/sj.gt.3302144
-
Zhang YC, Powers M, Wasserfall C, Brusko T, Song S, Flotte T, Snyder RO, Potter M, Scott-Jorgensen M, Campbell-Thompson M, Crawford JM, Nick HS, Agarwal A, Ellis TM, Atkinson MA (2004) Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunity. Gene Ther 11:233-240 10.1038/sj.gt.3302144
-
(2004)
Gene Ther.
, vol.11
, pp. 233-240
-
-
Zhang, Y.C.1
Powers, M.2
Wasserfall, C.3
Brusko, T.4
Song, S.5
Flotte, T.6
Snyder, R.O.7
Potter, M.8
Scott-Jorgensen, M.9
Campbell-Thompson, M.10
Crawford, J.M.11
Nick, H.S.12
Agarwal, A.13
Ellis, T.M.14
Atkinson, M.A.15
-
54
-
-
0742307402
-
Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults
-
10.1089/10430340460732490
-
Flotte TR, Brantly ML, Spencer LT, Byrne BJ, Spencer CT, Baker DJ, Humphries M (2004) Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults. Hum Gene Ther 15:93-128 10.1089/10430340460732490
-
(2004)
Hum. Gene Ther.
, vol.15
, pp. 93-128
-
-
Flotte, T.R.1
Brantly, M.L.2
Spencer, L.T.3
Byrne, B.J.4
Spencer, C.T.5
Baker, D.J.6
Humphries, M.7
-
55
-
-
0013442744
-
AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B
-
10.1182/blood-2002-10-3296
-
Manno CS, Chew AJ, Hutchison S, Larson PJ, Herzog RW, Arruda VR, Tai SJ, Ragni MV, Thompson A, Ozelo M, Couto LB, Leonard DG, Johnson FA, McClelland A, Scallan C, Skarsgard E, Flake AW, Kay MA, High KA, Glader B (2003) AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 101:2963-2972 10.1182/blood-2002-10-3296
-
(2003)
Blood
, vol.101
, pp. 2963-2972
-
-
Manno, C.S.1
Chew, A.J.2
Hutchison, S.3
Larson, P.J.4
Herzog, R.W.5
Arruda, V.R.6
Tai, S.J.7
Ragni, M.V.8
Thompson, A.9
Ozelo, M.10
Couto, L.B.11
Leonard, D.G.12
Johnson, F.A.13
McClelland, A.14
Scallan, C.15
Skarsgard, E.16
Flake, A.W.17
Kay, M.A.18
High, K.A.19
Glader, B.20
more..
-
56
-
-
2342457825
-
Clinical gene transfer studies for hemophilia B
-
10.1055/s-2004-825639
-
High KA (2004) Clinical gene transfer studies for hemophilia B. Semin Thromb Hemost 30:257-267 10.1055/s-2004-825639
-
(2004)
Semin. Thromb. Hemost.
, vol.30
, pp. 257-267
-
-
High, K.A.1
-
57
-
-
0037089331
-
Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy
-
10.1182/blood.V99.8.2670
-
Mount JD, Herzog RW, Tillson DM, Goodman SA, Robinson N, McCleland ML, Bellinger D, Nichols TC, Arruda VR, Lothrop CD Jr, High KA (2002) Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy. Blood 99:2670-2676 10.1182/blood.V99.8.2670
-
(2002)
Blood
, vol.99
, pp. 2670-2676
-
-
Mount, J.D.1
Herzog, R.W.2
Tillson, D.M.3
Goodman, S.A.4
Robinson, N.5
McCleland, M.L.6
Bellinger, D.7
Nichols, T.C.8
Arruda, V.R.9
Lothrop Jr., C.D.10
High, K.A.11
-
58
-
-
0034849318
-
Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation
-
10.1006/mthe.2001.0442
-
Herzog RW, Mount JD, Arruda VR, High KA, Lothrop CD Jr (2001) Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation. Mol Ther 4:192-200 10.1006/mthe.2001.0442
-
(2001)
Mol. Ther.
, vol.4
, pp. 192-200
-
-
Herzog, R.W.1
Mount, J.D.2
Arruda, V.R.3
High, K.A.4
Lothrop Jr., C.D.5
-
59
-
-
0032789423
-
Transduction of renal cells in vitro and in vivo by adeno-associated virus gene therapy vectors
-
1:CAS:528:DyaK1MXmtVSmtrc%3D
-
Lipkowitz MS, Hanss B, Tulchin N, Wilson PD, Langer JC, Ross MD, Kurtzman GJ, Klotman PE, Klotman ME (1999) Transduction of renal cells in vitro and in vivo by adeno-associated virus gene therapy vectors. J Am Soc Nephrol 10:1908-1915 1:CAS:528:DyaK1MXmtVSmtrc%3D
-
(1999)
J. Am. Soc. Nephrol.
, vol.10
, pp. 1908-1915
-
-
Lipkowitz, M.S.1
Hanss, B.2
Tulchin, N.3
Wilson, P.D.4
Langer, J.C.5
Ross, M.D.6
Kurtzman, G.J.7
Klotman, P.E.8
Klotman, M.E.9
-
60
-
-
12244274327
-
Evidence that bone morphogenetic protein 4 has multiple biological functions during kidney and urinary tract development
-
10.1046/j.1523-1755.2003.00834.x
-
Miyazaki Y, Oshima K, Fogo A, Ichikawa I (2003) Evidence that bone morphogenetic protein 4 has multiple biological functions during kidney and urinary tract development. Kidney Int 63:835-844 10.1046/j.1523-1755.2003.00834.x
-
(2003)
Kidney Int.
, vol.63
, pp. 835-844
-
-
Miyazaki, Y.1
Oshima, K.2
Fogo, A.3
Ichikawa, I.4
-
61
-
-
0035164441
-
Genetically modified bone marrow-derived vehicle cells site specifically deliver an anti-inflammatory cytokine to inflamed interstitium of obstructive nephropathy
-
1:CAS:528:DC%2BD3MXis1emsA%3D%3D
-
Yamagishi H, Yokoo T, Imasawa T, Mitarai T, Kawamura T, Utsunomiya Y (2001) Genetically modified bone marrow-derived vehicle cells site specifically deliver an anti-inflammatory cytokine to inflamed interstitium of obstructive nephropathy. J Immunol 166:609-616 1:CAS:528:DC%2BD3MXis1emsA%3D%3D
-
(2001)
J. Immunol.
, vol.166
, pp. 609-616
-
-
Yamagishi, H.1
Yokoo, T.2
Imasawa, T.3
Mitarai, T.4
Kawamura, T.5
Utsunomiya, Y.6
-
62
-
-
0037792920
-
Gene delivery using human cord blood-derived CD34+cells into inflamed glomeruli in NOD/SCID mice
-
10.1046/j.1523-1755.2003.00046.x
-
Yokoo T, Ohashi T, Utsunomiya Y, Okamoto A, Suzuki T, Shen JS, Tanaka T, Kawamura T, Hosoya T (2003) Gene delivery using human cord blood-derived CD34+cells into inflamed glomeruli in NOD/SCID mice. Kidney Int 64:102-109 10.1046/j.1523-1755.2003.00046.x
-
(2003)
Kidney Int.
, vol.64
, pp. 102-109
-
-
Yokoo, T.1
Ohashi, T.2
Utsunomiya, Y.3
Okamoto, A.4
Suzuki, T.5
Shen, J.S.6
Tanaka, T.7
Kawamura, T.8
Hosoya, T.9
-
63
-
-
0036265537
-
Hepatic and renal differentiation from blood-borne stem cells
-
10.1038/sj.gt.3301720
-
Forbes SJ, Poulsom R, Wright NA (2002) Hepatic and renal differentiation from blood-borne stem cells. Gene Ther 9:625-630 10.1038/sj.gt.3301720
-
(2002)
Gene Ther.
, vol.9
, pp. 625-630
-
-
Forbes, S.J.1
Poulsom, R.2
Wright, N.A.3
-
64
-
-
0036261824
-
Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors
-
10.1038/sj.gt.3301723
-
Rafii S, Heissig B, Hattori K (2002) Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors. Gene Ther 9:631-641 10.1038/sj.gt.3301723
-
(2002)
Gene Ther.
, vol.9
, pp. 631-641
-
-
Rafii, S.1
Heissig, B.2
Hattori, K.3
-
65
-
-
0037498544
-
Bone marrow stem cells contribute to healing of the kidney
-
Poulsom R, Alison MR, Cook T, Jeffery R, Ryan E, Forbes SJ, Hunt T, Wyles S, Wright NA (2003) Bone marrow stem cells contribute to healing of the kidney. J Am Soc Nephrol 14 [Suppl 1]: S48-S54
-
(2003)
J. Am. Soc. Nephrol.
, vol.14
, Issue.SUPPL. 1
-
-
Poulsom, R.1
Alison, M.R.2
Cook, T.3
Jeffery, R.4
Ryan, E.5
Forbes, S.J.6
Hunt, T.7
Wyles, S.8
Wright, N.A.9
-
66
-
-
0032910706
-
Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis
-
10.1046/j.1523-1755.1999.00275.x
-
Isaka Y, Akagi Y, Ando Y, Tsujie M, Sudo T, Ohno N, Border WA, Noble NA, Kaneda Y, Hori M, Imai E (1999) Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 55:465-475 10.1046/j.1523-1755.1999.00275.x
-
(1999)
Kidney Int.
, vol.55
, pp. 465-475
-
-
Isaka, Y.1
Akagi, Y.2
Ando, Y.3
Tsujie, M.4
Sudo, T.5
Ohno, N.6
Border, W.A.7
Noble, N.A.8
Kaneda, Y.9
Hori, M.10
Imai, E.11
-
67
-
-
0345628010
-
Fas ligand gene transfer to renal allografts in rats: Effects on allograft survival
-
1:CAS:528:DyaK1cXhtVymtLk%3D
-
Swenson KM, Ke B, Wang T, Markowitz JS, Maggard MA, Spear GS, Imagawa DK, Goss JA, Busuttil RW, Seu P (1998) Fas ligand gene transfer to renal allografts in rats: Effects on allograft survival. Transplantation 65:155-160 1:CAS:528:DyaK1cXhtVymtLk%3D
-
(1998)
Transplantation
, vol.65
, pp. 155-160
-
-
Swenson, K.M.1
Ke, B.2
Wang, T.3
Markowitz, J.S.4
Maggard, M.A.5
Spear, G.S.6
Imagawa, D.K.7
Goss, J.A.8
Busuttil, R.W.9
Seu, P.10
-
68
-
-
0034026805
-
CTLA4Ig gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allograft
-
1:CAS:528:DC%2BD3cXisFertLo%3D
-
Tomasoni S, Azzollini N, Casiraghi F, Capogrossi MC, Remuzzi G, Benigni A (2000) CTLA4Ig gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allograft. J Am Soc Nephrol 11:747-752 1:CAS:528:DC%2BD3cXisFertLo%3D
-
(2000)
J. Am. Soc. Nephrol.
, vol.11
, pp. 747-752
-
-
Tomasoni, S.1
Azzollini, N.2
Casiraghi, F.3
Capogrossi, M.C.4
Remuzzi, G.5
Benigni, A.6
-
69
-
-
4043147849
-
Favorable effect of cotransfection with TGF-beta and CTLA4Ig of the donor kidney on allograft survival
-
10.1159/000077611
-
Tomasoni S, Longaretti L, Azzollini N, Gagliardini E, Mister M, Buehler T, Remuzzi G, Benigni A (2004) Favorable effect of cotransfection with TGF-beta and CTLA4Ig of the donor kidney on allograft survival. Am J Nephrol 24:275-283 10.1159/000077611
-
(2004)
Am. J. Nephrol.
, vol.24
, pp. 275-283
-
-
Tomasoni, S.1
Longaretti, L.2
Azzollini, N.3
Gagliardini, E.4
Mister, M.5
Buehler, T.6
Remuzzi, G.7
Benigni, A.8
|